Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer
This study is ongoing, but not recruiting participants.
Study NCT00459810 Information provided by OHSU Knight Cancer Institute
First Received: April 11, 2007 Last Updated: September 30, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
therapeutic estradiol
paclitaxel poliglumex
Additional drug interventions recognized in this trial
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Paclitaxel
Polyestradiol phosphate
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Contraceptive Agents
Contraceptive Agents, Female
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Back to top of Main Content
